| Dr James C Wendt, MD | |
|
620 N Alpha St, Grand Island, NE 68803-4316 | |
| (308) 381-0473 | |
| (308) 381-2616 |
| Full Name | Dr James C Wendt |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 620 N Alpha St, Grand Island, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629070347 | NPI | - | NPPES |
| 340004907 | Other | NE | RAILROAD MEDICARE |
| 47070756913 | Medicaid | NE | |
| 1223 | Other | NE | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 15992 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr James C Wendt, MD 620 N Alpha St, Grand Island, NE 68803-4316 Ph: (308) 381-0473 | Dr James C Wendt, MD 620 N Alpha St, Grand Island, NE 68803-4316 Ph: (308) 381-0473 |
News Archive
Researchers reported today that Soliris® (eculizumab), a first-in-class terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc., may provide clinical benefits to patients with thrombotic microangiopathy (TMA) resulting from uncontrolled complement activation. TMA, the formation of blood clots in capillaries and small arteries, can lead to life-threatening damage in multiple organs including kidney failure, thrombocytopenia (abnormally low platelet count) and anemia.
A new study published in the journal Ultrasound in Obstetrics & Gynecology reveals that fetal tracheal occlusion (FETO) improves infant survival rate in severe cases of congenital diaphragmatic hernia (CDH).
For women who have undergone mastectomy for breast cancer, breast reconstruction using the abdominal "DIEP flap" provides good long-term quality of life (QOL)—similar to that of women without breast cancer, reports a study in the May issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
St. John Hospital and Medical Center in Detroit and Avinger, Inc., a medical device company focused on the development of innovative devices to combat peripheral artery disease, announced today the enrollment of the first patient in the CONNECT (Chronic TOtal OcclusioN CrossiNg with thE WildCat CatheTer) clinical trial.
› Verified 6 days ago
Dr. Gregory L. Alberts, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 620 N Alpha St, Grand Island, NE 68803 Phone: 308-381-0473 Fax: 308-381-2616 | |
Dr. Lawrence W. Hake, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 620 N Alpha St, Grand Island, NE 68803 Phone: 308-381-0473 Fax: 308-381-2616 |